CATHERINE CHUDZINSKI: Open Payments
NPI 1225681935 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 6 payments from 6 companies in 2025. Trend: 2023 $925 · 2024 $0 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $127 |
| Novo Nordisk Inc | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| Boston Scientific Corporation | 1 | $23 |
Products named: REPATHA, Ozempic, JARDIANCE, LOKELMA, CAMZYOS, General - Pain Management.
Industry payments across AZ — which companies pay providers there.
